CCR5 and CXCR4 tropism and CD4 kinetics in HIV-1 infection
CCR5 and CXCR4 tropism and CD4 kinetics in HIV-1 infection
批准号:
G0500628/1
负责人:
Derek Macallan
金额:
$33.68万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
HIV infection causes disease by progressively depleting the number of a particular type of immune cells, ?CD4 cells?. We do not fully understand how infection results in loss of CD4 cells over time. Although HIV infects and destroys CD4 cells directly, the body normally just makes more cells to replace the lost ones. We believe that what determines how HIV affects the body?s CD4 cells is the exact type of cell it infects. There are several sub-types of CD4 cells. Different strains of virus prefer to infect different sub-types of CD4 cell according to the receptors (like locking devices) on the cell surface. Two receptors, ?CCR5? and ?CXCR4?, appear particularly important. We hypothesise that the interaction between the viral CCR5/CXCR4 preference (?tropism?), the type of cell infected and the speed at which those cells are dividing determines the long-term effect of HIV on CD4 cell numbers. To investigate this concept, we will measure how fast different sub-types of CD4 cells are dividing and disappearing within the body. Although much has been learnt from investigating cells and viruses in test tubes, answering such questions about CD4 loss can only be done by studying virus and CD4 cells within the body of people infected with HIV. We have recently developed a way of doing this using glucose containing an excess of deuterium. Deuterium is a naturally-occurring non-radioactive form (or isotope) of hydrogen which behaves exactly like hydrogen but can be measured using a mass spectrometer. We will give deuterium-labelled glucose (which is harmless) as a drink (half-hourly for 10 hours) to people with HIV infection, then take blood samples over the following 3 weeks. The glucose is used by dividing, but not non-dividing, cells to make new DNA. By separating the cells into their subtypes and measuring the deuterium in their DNA using a mass spectrometer, we can measure how fast CD4 subtypes divide and how long they survive in the body. We will also test the virus in the bloodstream for its CCR5/CXCR4 tropism. We will compare the results to those from a group of people without HIV infection. We will use these measurements to create a mathematical picture or ?model? of how HIV interacts with different immune cells to explain why CD4 cells are destroyed slowly over time and why changes in viral tropism trigger accelerated loss of CD4 cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
How do lymphocyte proliferation and survival contribute to immunological memory in health, ageing and HIV infection?
-
批准号:G1001052/1
-
项目类别:Research Grant
-
资助金额:$77.22万
-
财政年份:2011
-
负责人:Derek Macallan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
靶向 CAFs 联合 CXCR4/SDF1 轴阻断:重编程基质微环境突破三阴乳腺癌转移与免疫耐药的机制研究
-
批准号:2026JJ82458
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周燕
-
依托单位:
CGRP通过调控SDF-1/CXCR4轴改善先天性胫骨假关节的骨代谢失衡及骨愈合机制
-
批准号:2026JJ81835
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘喜平
-
依托单位:
基于SDF-1/CXCR4信号通路探讨低强度脉冲超声促进牵张成骨的作用及其机制研究
-
批准号:2026JJ82627
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:阳芬
-
依托单位:
CXCR4调控Tregs乳酸代谢失衡在ICI心肌炎中的作用及机制研究
-
批准号:Z25H020002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张宁
-
依托单位:
胆固醇硫酸酯促进CXCR4膜定位及造血干细胞归巢的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:高海
-
依托单位:
基于近红外光学平台介导的肝癌CXCR4靶向早期分子诊疗及抑制复发转移关键技术研究
-
批准号:2025JJ50495
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:齐硕
-
依托单位:
基于IDH1琥珀酰化修饰调控
CXCL12/CXCR4轴探讨驻车丸防治肠炎相
关结直肠癌的作用及机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:张晓君
-
依托单位:
用于SPECT的新型CXCR4靶向分子探针的设计与评价
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张晓阳
-
依托单位:
肿瘤源性G-CSF经由IFITM1介导的CXCR4降解增加中性粒细胞浸润促乳腺癌肝转移的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王伟华
-
依托单位:
消退素D1抑制CXCR4介导的中性粒细胞rTEM减轻脓毒症肺损伤的作用及机制研究
-
批准号:2025JJ81022
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:程杨
-
依托单位: